Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 27:12:702617.
doi: 10.3389/fpsyt.2021.702617. eCollection 2021.

Statins in Depression: An Evidence-Based Overview of Mechanisms and Clinical Studies

Riccardo De Giorgi  1   2 , Nicola Rizzo Pesci  3 , Alice Quinton  1   2 , Franco De Crescenzo  1   2 , Philip J Cowen  1   2 , Catherine J Harmer  1   2
Affiliations

Statins in Depression: An Evidence-Based Overview of Mechanisms and Clinical Studies

Riccardo De Giorgi et al. Front Psychiatry. .

Abstract

Background: Depression is a leading cause of disability, burdened by high levels of non-response to conventional antidepressants. Novel therapeutic strategies targeting non-monoaminergic pathways are sorely needed. The widely available and safe statins have several putative mechanisms of action, especially anti-inflammatory, which make them ideal candidates for repurposing in the treatment of depression. A large number of articles has been published on this topic. The aim of this study is to assess this literature according to evidence-based medicine principles to inform clinical practise and research. Methods: We performed a systematic review of the electronic databases MEDLINE, CENTRAL, Web of Science, CINAHL, and ClinicalTrials.gov, and an unstructured Google Scholar and manual search, until the 9th of April 2021, for all types of clinical studies assessing the effects of statins in depression. Results: Seventy-two studies were retrieved that investigated the effects of statins on the risk of developing depression or on depressive symptoms in both depressed and non-depressed populations. Fifteen studies specifically addressed the effects of statins on inflammatory-related symptoms of anhedonia, psychomotor retardation, anxiety, and sleep disturbances in depression. Most studies suggested a positive effect of statins on the occurrence and severity of depression, with fewer studies showing no effect, while a minority indicated some negative effects. Limitations: We provide a narrative report on all the included studies but did not perform any quantitative analysis, which limits the strength of our conclusions. Conclusions: Robust evidence indicates that statins are unlikely to lead to depressive symptoms in the general population. Promising data suggest a potential role for statins in the treatment of depression. Further clinical studies are needed, especially in specific subgroups of patients identified by pre-treatment assessments of inflammatory and lipid profiles.

Keywords: HMG 3-hydroxy-3-methylglutaryl; antidepressant; depression; mechanism; review; statin.

PubMed Disclaimer

Conflict of interest statement

CH has received consultancy fees from P1vital, Janssen, Sage Pharmaceuticals, Zogenix, Pfizer, and Lundbeck outside of the current work. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Overview of potential mechanisms underlying the antidepressant or depressogenic effects of statins.
Figure 2
Figure 2
Flow chart of the included/excluded studies.
See this image and copyright information in PMC

References

    1. James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. . Global, regional, and national incidence, prevalence, and years lived with disability for 354 Diseases and Injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. (2018) 392:1789–858. 10.1016/S0140-6736(18)32279-7 - DOI - PMC - PubMed
    1. Kennedy SH. A review of antidepressant therapy in primary care: current practices and future directions. Prim Care Comp J Clin Psychiatry. (2013) 15:PCC.12r01420. 10.4088/PCC.12r01420 - DOI - PMC - PubMed
    1. Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, et al. . Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. (2018) 391:1357–66. 10.1016/S0140-6736(17)32802-7 - DOI - PMC - PubMed
    1. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. . Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. (2006) 163:1905–17. 10.1176/ajp.2006.163.11.1905 - DOI - PubMed
    1. Harmer CJ, Duman RS, Cowen PJ. How do antidepressants work? New perspectives for refining future treatment approaches. Lancet Psychiatry. (2017) 4:409–18. 10.1016/S2215-0366(17)30015-9 - DOI - PMC - PubMed

Publication types